621. Lymphomas: Translational Molecular and Genetic: Poster II

Evaluating targeted long read sequencing as a diagnostic tool for burkitt lymphoma

Discovery of an undocumented pattern of intron retention that is abundant in healthy B cells and circumvented in Waldenstrom s macroglobulinemia impacting genes driving cellular growth and survival

Regulatory network analysis identifies changes in ahr TFAP4 and AP 1 transcription factors as top drivers of symptomatic disease progression in Waldenstrom s macroglobulinemia

Prognostic value of minimal residual disease detection by circulating tumor DNA in Hodgkin lymphoma

Germline osmr mutation drives familial unicentric castleman disease with osteosclerosis

Combining next generation sequencing and optical genome mapping techniques to analyze genomic abnormalities in marginal zone lymphoma

Hi c FFPE sequencing analysis is highly concordant with FISH and detects additional variants informing diagnosis and treatment in diffuse large B cell lymphoma

IRF2BP2 mutations activate IL 1β mediated NF κB signaling and confer actionable anti IL 1β sensitivity in DLBCL

Impact of ALK fusion variants and genetic profiles on prognosis in Chinese pediatric patients with ALK positive anaplastic large cell lymphoma

Developing artificial intelligence based transcriptomic signature for the diagnosis of dark zone lymphoma in patients without MYC gene rearrangement

Molecular distinctiveness of duodenal type follicular lymphoma revealed by integrated multi omic analysis

Tracing the evolution of clonal T cell responses in LGL leukemia with single cell whole genome sequencing

A single cell co expression score of MYC and BCL2 identifies high risk BCR addicted DLBCL benefiting from polatuzumab vedotin in the POLARIX trial

The role of MYD88L265P in extranodal manifestations of B cell non Hodgkin lymphomas